nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2023, 07, v.41 219-222
养元健骨汤对老年骨质疏松症骨折疗效、骨密度及骨折愈合速度影响研究
基金项目(Foundation): 河南省中医药科学研究专项(2017ZYBJ20)
邮箱(Email):
DOI: 10.13193/j.issn.1673-7717.2023.07.042
摘要:

目的 观察养元健骨汤对老年骨质疏松症骨折患者疗效、骨密度及骨折愈合速度影响。方法 纳入90例老年骨质疏松症骨折患者,随机分为观察组及对照组,每组45例。对照组给予骨化三醇软胶囊,观察组在对照组基础上给予养元健骨汤治疗,两组均治疗8周。比较两组患者的临床疗效、骨代谢指标、骨密度及骨折愈合速度。结果 两组患者治疗8周后,观察组总有效率为86.67%(39/45),显著高于对照组66.67%(30/45)(P<0.05);两组患者治疗后血清Ⅰ型原胶原氨基端前肽(procollagen I N-terminal peptide, PINP)水平均较治疗前显著降低(P<0.05),血清骨钙素(osteocalcin, OC)均较治疗前显著升高(P<0.05),观察组β-胶原特殊序列(β-isomerized C-terminal telopeptides, β-CTX)较治疗前显著降低(P<0.05),对照组β-CTX与治疗前相比有降低趋势但无统计学意义(P>0.05)。且观察组指标降低或升高幅度均显著优于对照组(P<0.05);两组患者经治疗后骨密度均较治疗前显著提高(P<0.05),且观察组骨密度变化显著优于对照组(P<0.05);两组患者治疗后,观察组肱骨骨折愈合时间为(7.5±1.2)周、股骨骨折愈合时间为(10.2±2.1)周、胫骨骨折愈合时间为(10.1±1.3)周,对照组肱骨骨折愈合时间为(8.6±1.1)周、股骨骨折愈合时间为(11.9±2.3)周、胫骨骨折愈合时间为(12.4±1.4)周,观察组骨折愈合时间均短于对照组,差异有统计学意义(P<0.05)。结论 养元健骨汤显著提高老年骨质疏松症骨折患者临床疗效,改善患者骨代谢,提高骨密度,促进骨折愈合。

Abstract:

Objective To observe the effect of Yangyuan Jiangu Decoction(养元健骨汤) on the curative effect, bone mineral density and fracture healing speed of elderly patients with osteoporotic fractures. Methods Ninety elderly patients with osteoporosis fractures were included and randomly divided into an observation group and a control group, with 45 cases in each group. The control group was given calcitriol soft capsules, and the observation group was given Yangyuan Jiangu Decoction on the basis of the control group, both groups were treated for 8 weeks. The clinical efficacy, bone metabolism indexes, bone mineral density, and fracture healing speed were compared between the two groups. Results After 8 weeks of treatment in the two groups, the total effective rate of the observation group was 86.67%(39/45),which was significantly higher than that of the control group 66.67%(30/45)(P<0.05). Procollagen I N-terminal peptide(PINP) levels were significantly lower than those before treatment(P<0.05). The levels of osteocalcin(OC) were significantly higher than those before treatment(P<0.05). The levels of β-isomerized C-terminal telopeptides(β-CTX) were significantly lower than those before treatment(P<0.05) and β-CTX in the control group had a decreasing trend compared with that before treatment, but there was no statistical significance(P>0.05). The decrease or increase of the indexes in the observation group was significantly better than that in the control group(P<0.05). The bone mineral density of the two groups after treatment was significantly increased compared with that before treatment(P<0.05),and the change of the bone mineral density of the observation group was significantly better than that of the control group(P<0.05). After treatment in the observation group, the healing time of humerus fractures was(7.5±1.2) weeks, the healing time of femoral fractures was(10.2±2.1) weeks and the healing time of tibia fractures was(10.1±1.3) weeks. In the control group, the healing time of humerus fractures was(8.6±1.1) weeks, the healing time of femoral fractures was(11.9±2.3) weeks and the healing time of tibia fractures was(12.4±1.4) weeks. The fracture healing time of the observation group was shorter than that of the control group and the difference was statistically significant(P<0.05). Conclusion Yangyuan Jiangu Decoction significantly improves the clinical efficacy and bone metabolism, increases bone density and promotes fracture healing of elderly patients with osteoporosis and fractures.

参考文献

[1] CATHERINE BREE JOHNSTON,MEENAKSHI DAGAR.Osteoporosis in older adults[J].Medical Clinics of North America,2020,104(5):873-884.

[2] 温经渊,曾晗冰,吴连国.骨质疏松症中医辨证分型研究进展[J].安徽中医药大学学报,2021,40(5):101-104.

[3] 张馨心,毛晓艳,毛春焕,等.骨质疏松性骨折患者血清25(OH)D、TGF-β1、网膜素-1与MRI信号特点的相关性分析[J].东南大学学报(医学版),2020,39(6):773-779.

[4] 杨弦弦,唐文革,汤成,等.重庆市40岁及以上居民骨质疏松症流行现状及影响因素分析[J].中国慢性病预防与控制,2021,29(10):741-745.

[5] 付银锋,史栋梁.仙灵骨葆胶囊联合唑来磷酸静脉滴注和碳酸钙D3片对老年骨质疏松患者骨密度及骨转换的影响[J].中国老年学杂志,2021,41(22):5015-5017.

[6] 季康,张中伟,徐红伟.唑来膦酸注射液联合降钙素治疗老年骨质疏松的疗效及其对血清IL-6、TNF-α水平的影响[J].中国老年学杂志,2020,40(2):356-359.

[7] REID I R.A broader strategy for osteoporosis interventions[J].Nat Rev Endocrinol,2020,16(6):333-339.

[8] 夏维波,章振林,林华,等.原发性骨质疏松症诊疗指南(2017)[J].中国骨质疏松杂志,2019,25(3):281-309.

[9] 郑莜萸.中药新药临床研究指导原则(试行)[S].北京:中国医药科技出版社,2002:68-69.

[10] 苏佳灿,侯志勇,刘国辉,等.中国骨质疏松性骨折围手术期处理专家共识(2018)[J].中国临床医学,2018,25(5):860-867.

[11] 罗薇,陈钢,马骁,等.中老年健康体检人群骨密度调查及骨量异常患病率分析[J].中日友好医院学报,2021,35(6):328-331.

[12] 赵官平,万小明,万宣,等.6258例绝经后妇女骨质疏松症流行病学调查及其发病相关因素分析[J].江西中医药,2021,52(12):23-25.

[13] 杜超,周维天,夏伟.岳池县中老年女性骨代谢指标与骨质疏松的相关性研究[J].华南预防医学,2021,47(8):985-988,993.

[14] 颜丽娜,饶高峰,史朝红.老年女性骨质疏松发病影响因素及综合干预效果[J].中国妇幼保健,2021,36(7):1527-1530.

[15] 唐鸣,李菁,邹重文,等.老年常见慢性病女性骨质疏松发病风险及综合干预疗效分析[J].中国妇幼健康研究,2019,30(1):96-99.

[16] ROZENBERG S,AL-DAGHRI N,AUBERTIN-LEHEUDRE M,et al.Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?[J].Osteoporos Int,2020,31(prepublish):1-16.

[17] PIKE J W,MEYER M B.The unsettled science of nonrenal calcitriol production and its clinical relevance[J].J Clin Invest,2020,21(2):2172-2175.

[18] 索荣,刘行,赵辉.维生素D3通过VDR-p38途径抑制内皮细胞VCAM-1表达的研究[J].重庆医学,2020,49(24):4045-4049,4054.

[19] 罗小光,黄翠婵,刘桂华.鹿瓜多肽注射液、骨化三醇联合来氟米特在老年类风湿性关节炎合并骨质疏松中的应用[J].世界中西医结合杂志,2020,15(10):1881-1884,1941.

[20] 金镇雄,舒冰,王乾,等.中医辨证分型治疗骨质疏松性骨折的研究进展[J].中国骨质疏松杂志,2020,26(12):1843-1846.

[21] 严斐霞,谢永艳,陈畅,等.熟地黄炮制过程中的化学成分变化和药理作用研究进展[J].时珍国医国药,2021,32(10):2493-2495.

[22] 周群,曾弦,黄丹,等.骨碎补化学成分和生物活性研究进展[J].世界科学技术-中医药现代化,2021,23(8):2727-2741.

[23] 吴海波,禹志军,白曼莫,等.养元健骨汤联合针灸对风寒湿痹型膝骨性关节炎患者的临床疗效[J].中成药,2021,43(12):3565-3567.

[24] 王湛,王毅,冯凯强,等.骨转换标志物CTX-1和PINP预测骨质疏松骨折的研究进展[J].中国骨质疏松杂志,2021,27(7):1084-1087.

[25] 陈建丰,韩晓芳,翟斐,等.老年2型糖尿病患者血清β-CTX、OC、PINP、25(OH)D_3表达与血糖、胰岛素水平的关联性[J].中国临床研究,2020,33(7):959-962.

基本信息:

DOI:10.13193/j.issn.1673-7717.2023.07.042

中图分类号:R259

引用信息:

[1]高海燕,韦灵杰,赵洪波.养元健骨汤对老年骨质疏松症骨折疗效、骨密度及骨折愈合速度影响研究[J].中华中医药学刊,2023,41(07):219-222.DOI:10.13193/j.issn.1673-7717.2023.07.042.

基金信息:

河南省中医药科学研究专项(2017ZYBJ20)

发布时间:

2022-11-07

出版时间:

2022-11-07

网络发布时间:

2022-11-07

检 索 高级检索